Skip to main content
. 2017 Oct 14;22(10):1726. doi: 10.3390/molecules22101726

Table 3.

Incidence of complications and mortality rate according to age.

Parameter Total
(n = 176)
Non-Elderly
(≤60 years, n = 115)
Elderly
(>60 years, n = 61)
p
Respiratory complications (%) 39 (22.2) 20 (17.4) 19 (31.1) 0.037
 Pneumonia (%) 14 (8.0) 7 (6.1) 7 (11.5) 0.209
 RF 1 (%) 35 (19.9) 18 (15.7) 17 (27.9) 0.050
GI 2 complications (%) 38 (21.6) 25 (21.7) 13 (21.3) 0.948
 Bleeding (%) 24 (13.6) 18 (15.7) 6 (9.8) 0.285
 Perforation (%) 15 (8.5) 9 (7.8) 6 (9.8) 0.649
 Peritonitis/Mediastinitis (%) 14 (8.0) 6 (5.2) 8 (13.1) 0.065
 Fistula (%) 2 (1.1) 0 (0.0) 2 (3.3) 0.119
 Stricture (%) 2 (1.1) 2 (1.7) 0 (0.0) 0.300
Leukocytosis (%) 32 (18.2) 11 (9.6) 21 (34.4) 0.001
Antibiotic usage (%) 95 (54.0) 56 (48.7) 39 (63.9) 0.050
Mean length of hospital stay (%) 6.0 (1–45)
(n = 149)
4.8 (1–22)
(n = 97)
8.2 (1–45)
(n = 52)
0.003
 
Mortality (%) 27 (15.3) 13 (11.3) 14 (23.0) 0.041

1 RF—respiratory failure, 2 GI—gastrointestinal. Pearson’s χ2 test, Fischer’s exact test for n < 5, p ≤ 0.05.